Physician profile
Eric Howell
NPI 1285834788
$5,087.99
in general payments reported to CMS, 2019-2025
23 companies · $534 in 2025
The $534 reported for 2025 was less than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,648 · 2020: $106 · 2021: $438 · 2022: $920 · 2023: $906 · 2024: $536 · 2025: $534.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,896 · Education: $79.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,896.42 |
| Education | $79.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,616.66 | 2019-2025 | |
| Allergan, INC. | $1,032.36 | 2019-2020 | |
| Merz North America, INC. | $549.78 | 2019-2023 | |
| Leo Pharma INC. | $466.09 | 2021-2025 | Adbry, Anzupgo |
| Janssen Biotech, INC. | $442.64 | 2019-2024 | Tremfya |
| Amgen INC. | $188.13 | 2021-2025 | Otezla, Otezla |
| Novartis Pharmaceuticals Corporation | $165.91 | 2019-2025 | |
| Organogenesis INC. | $116.07 | 2019 | |
| Pfizer INC. | $115.51 | 2019-2023 | |
| Lilly USA, LLC | $78.44 | 2022-2024 | Olumiant, Taltz |
| Regeneron Healthcare Solutions, INC. | $72.73 | 2021 | |
| Genzyme Corporation | $37.15 | 2024 | |
| Galderma Laboratories, L.P. | $33.52 | 2021 | |
| Helsinn Therapeutics (U.S.), INC. | $31.66 | 2021-2023 | Valchlor |
| Incyte Corporation | $22.76 | 2023 | Opzelura |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Celgene Corporation | $19.35 | 2019 | |
| Sun Pharmaceutical Industries INC. | $19.01 | 2023 | Absorica Ld, Winlevi |
| E.R. Squibb & Sons, L.L.C. | $15.14 | 2024 | Sotyktu |
| Paratek Pharmaceuticals, INC. | $14.95 | 2023 | Nuzyra |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $14.19 | 2019 | |
| Almirall LLC | $13.26 | 2023 | Seysara |
| Organon LLC | $13.12 | 2025 | Vtama |
| Strata Skin Sciences, INC. | $9.56 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Howell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.